Woman of the Week Podcast: Colleen Carter | PharmaVoice

Skip to main content

PharmaVoice stories and insights delivered to your inbox

Get the free daily newsletter read by industry leaders

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Read next

Permission granted by Merck & Co.

Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals

A subcutaneous version of Merck’s Keytruda was as effective as the infused version in a late-stage study, but the company won’t be the first to market.

By Michael Gibney • Nov. 21, 2024

Latest in WoW Podcast

Woman of the Week: Novartis’ Christy Siegel

By Taren Grom and Meagan Parrish
Woman of the Week: AmyriAD Therapeutics’ Sharon Rogers

By Taren Grom and Meagan Parrish
Woman of the Week: Stealth BioTherapeutics’ Reenie McCarthy

By Taren Grom

Get PharmaVoice in your inbox

The free newsletter covering the top industry headlines

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.